×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [12]
山东大学 [10]
中国医学科学院 北京... [8]
清华大学 [4]
厦门大学 [4]
武汉大学 [3]
更多...
内容类型
期刊论文 [55]
会议论文 [4]
学位论文 [3]
发表日期
2019 [2]
2018 [10]
2017 [8]
2016 [4]
2015 [13]
2014 [9]
更多...
学科主题
Biochemica... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共62条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:113/0
  |  
提交时间:2019/12/05
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2020/01/03
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
Multicentre laboratory validation of the nitrate reductase assay using liquid medium for the rapid detection of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis
期刊论文
TUBERCULOSIS, 2018, 卷号: 113
作者:
Huang, Zikun
;
Du, Jinghui
;
Deng, Zhen
;
Luo, Qing
;
Xiong, Guoliang
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/04
Mycobacterium tuberculosis
NRA
Drug susceptibility testing
Second-line drugs
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:
Zhang, Li
;
Cseh, Agnieszka
;
Peil, Barbara
;
Wang, Jie
;
Feng, Jifeng
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/05
afatinib
NSCLC
squamous cell carcinoma
second-line
Phase III
Chinese patients
Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China
期刊论文
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 卷号: 62, 期号: 4
作者:
Chen, Yong
;
Xu, Biao
;
Wu, Zheyuan
;
Wu, Jie
;
Shen, Xin
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
time to treatment
drug resistance
drug susceptibility testing
second-line drugs
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:
Hua, Jie
;
Shi, Si
;
Liang, Dingkong
;
Liang, Chen
;
Meng, Qingcai
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
pancreatic cancer
second-line
chemotherapy
targeted therapy
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer
期刊论文
THORACIC CANCER, 2018, 卷号: 9, 期号: 9
作者:
Lv, Chunxin
;
Liu, Xiuju
;
Zheng, Qiwen
;
Chen, Hanxiao
;
Yang, Xue
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/05
Second-line chemotherapy
small cell lung cancer
topoisomerase-1
topotecan
Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial
期刊论文
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 卷号: Vol.20 No.6, 页码: 768-774
作者:
Zhou, K.
;
Wen, F.
;
Zhang, P.
;
Zhou, J.
;
Zheng, H.
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/02/28
Cost-effectiveness
Sensitive
relapsed
smallcell
lung
cancer
Cisplatin
plus
etoposide
plus
irinotecan
Topotecan
Second-line
chemotherapy
Alleviation of post-contingency overloads by SOCP based corrective control considering TCSC and MTDC
期刊论文
IET GENERATION TRANSMISSION & DISTRIBUTION, 2018, 卷号: 12, 期号: 9
作者:
Bi, Ruyu
;
Lin, Tao
;
Chen, Rusi
;
Ye, Jing
;
Zhou, Xueming
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
DC power transmission
thyristor applications
mathematical programming
minimisation
flexible AC transmission systems
failure analysis
power generation reliability
power transmission reliability
power generation scheduling
renewable energy sources
search problems
pattern clustering
load shedding
load flow
power transmission control
power generation control
post-contingency overload alleviation
SOCP based corrective control
TCSC
MTDC
high-voltage direct current device
flexible AC transmission system
smart grid
cascading failures
DC blocking
post-contingency corrective control
large-scale renewable energy generation integration
artificial intelligence optimisation-based method
second-order cone programming CC optimisation model
SOCP-based CC optimisation model
meshed AC-DC power systems
optimisation variables
OV
heuristic search method
sensitivity index
clustering algorithm
overloaded lines
thyristor controlled series capacitor compensation levels
multiterminal direct current power
load shedding minimisation
generation rescheduling minimisation
power flow equations
computational efficiency
IEEE 30-bus test system
line outage
The Effectiveness of Sorafenib over Other Targeted Agents in the Second-Line Treatment of Metastatic Renal Cell Carcinoma: a Meta-Analysis
期刊论文
2018
作者:
Huang Hou-Feng
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Meta-analysis
Metastatic renal cell carcinoma
Second-line therapy
Sorafenib
©版权所有 ©2017 CSpace - Powered by
CSpace